Euformatics Picks Alliance Global as Middle Eastern Distributor

Dec 20, 2019 | staff reporter

NEW YORK – Alliance Global (AGBL) said that it has been named the exclusive distributor of Euformatics bioinformatics software in the Middle East, Asia, and Africa. Terms of the arrangement were not disclosed.

Euformatics, headquartered in Espoo, Finland, offers several software tools for interpretation of next-generation sequencing.

"As the use of NGS technology continues to expand, Middle East users will be able to gain a quick and in-depth insight into their data, while making sure that it is of the highest possible quality," Euformatics Business Development Manager Allyana Thomas said in a statement.

This is Dubai-based AGBL's second exclusive distribution deal of late. In October, the firm signed on to distribute PetaGene's PetaSuite genomic data compression software in the Middle East and much of Asia.

Filed under

distribution agreement

genome interpretation

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.